tiprankstipranks
Trending News
More News >
Medicamen Biotech Limited (IN:MEDICAMEQ)
:MEDICAMEQ
India Market

Medicamen Biotech Limited (MEDICAMEQ) Income Statement

Compare
0 Followers

Medicamen Biotech Limited Income Statement

Last quarter (Q3 2025), Medicamen Biotech Limited's total revenue was ₹451.42M, a decrease of -2.92% from the same quarter last year. In Q3, Medicamen Biotech Limited's net income was ₹29.22M. See Medicamen Biotech Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
₹ 1.63B₹ 1.79B₹ 1.41B₹ 1.15B₹ 1.13B
Gross Profit
₹ 389.90M₹ 852.01M₹ 687.74M₹ 479.88M₹ 335.16M
Operating Expenses
₹ 321.98M₹ 335.17M₹ 512.69M₹ 289.89M₹ 160.41M
Depreciation and Amortization
₹ 70.66M₹ 70.93M₹ 72.75M₹ 57.71M₹ 25.20M
EBITDA
₹ 201.02M₹ 245.66M₹ 277.12M₹ 258.07M₹ 204.25M
Operating Income
₹ 67.92M₹ 516.84M₹ 176.32M₹ 178.96M₹ 168.25M
Other Income/Expenses
₹ 30.88M₹ -386.09M₹ -285.50M₹ -265.37M₹ -149.47M
Pretax Income
₹ 98.80M₹ 130.76M₹ 170.45M₹ 180.94M₹ 163.94M
Net Income
₹ 71.08M₹ 109.31M₹ 148.44M₹ 148.98M₹ 121.29M
Per Share Metrics
Basic EPS
₹ 5.16₹ 8.63₹ 11.92₹ 12.19₹ 9.93
Diluted EPS
₹ 5.16₹ 8.63₹ 11.92₹ 12.19₹ 9.93
Weighted Average Shares Outstanding
0.00 12.66M 12.46M 12.22M 12.22M
Weighted Average Shares Outstanding (Diluted)
0.00 12.66M 12.46M 12.22M 12.22M
Currency in INR

Medicamen Biotech Limited Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis